Abstract:Background: The incidence of hypertriglyceridemia-associated acute pancreatitis (HTG-AP) is increasing globally and more so in China. The characteristics of liver-mediated metabolites and related key enzymes are rarely reported in HTG-AP. Chaiqin chengqi decoction (CQCQD) has been shown to protect against AP including HTG-AP in both patients and rodent models, but the underlying mechanisms in HTG-AP remain unexplored. Purpose: To assess the characteristics of liver-mediated metabolism and the therapeutic mechanisms of CQCQD in HTG-AP. Methods: Male human apolipoprotein C3 transgenic (hApoC3-Tg; leading to HTG) mice or wild-type littermates received 7 intraperitoneal injections of cerulein (100 μg/kg) to establish HTG-AP and CER-AP, respectively. In HTG-AP, some mice received CQCQD (5.5 g/kg) gavage at 1, 5 or 9 h after disease induction. AP severity and related liver injury were determined by serological and histological parameters; and underlying mechanisms were identified by lipidomics and molecular biology. Molecular docking was used to identify key interactions between CQCQD compounds and metabolic enzymes, and subsequently validated in vitro in hepatocytes. Results: HTG-AP was associated with increased disease severity indices including augmented liver injury compared to CER-AP. CQCQD treatment reduced severity and liver injury of HTG-AP. Glycerophospholipid (GPL) metabolism was the most disturbed pathway in HTG-AP in comparison to HTG alone. In HTG-AP, the mRNA level of GPL enzymes involved in phosphocholine (PC) and phosphatidylethanolamine (PE) synthesis (Pcyt1a, Pcyt2, Pemt, and Lpcat) were markedly upregulated in the liver. Of the GPL metabolites, lysophosphatidylethanolamine LPE(16:0) in serum of HTG-AP was significantly elevated and positively correlated with the pancreas histopathology score (r = 0.65). In vitro, supernatant from Pcyt2-overexpressing hepatocytes co-incubated with LPE(16:0) or phospholipase A2 (a PC- and PE-hydrolyzing enzyme) alone induced pancreatic acinar cell death. CQCQD treatment downregulated PCYT1a and PCYT2 enzyme levels in the liver. Hesperidin and narirutin were identified top two CQCQD compounds with highest affinity docking to PCYT1a and PCYT2. Both hesperidin and narirutin reduced the level of some GPL metabolites in hepatocytes. Conclusion: Liver-mediated GPL metabolism is excessively activated in HTG-AP with serum LPE(16:0) level correlating with disease severity. CQCQD reduces HTG-AP severity partially via modulating key enzymes in GPL metabolism pathway.

Digenic Inheritance and Gene-Environment Interaction in a Patient With Hypertriglyceridemia and Acute Pancreatitis

Identification of a Novel LPL Nonsense Variant and Further Insights into the Complex Etiology and Expression of Hypertriglyceridemia-Induced Acute Pancreatitis

Gene-environment Interaction Between APOA5 C.553g>t and Pregnancy in Hypertriglyceridemia-Induced Acute Pancreatitis.

Identification of a Novel and Heterozygous LMF1 Nonsense Mutation in an Acute Pancreatitis Patient with Severe Hypertriglyceridemia, Severe Obesity and Heavy Smoking

Compound but Non-Linked Heterozygous P.w14x and P.l279 V LPL Gene Mutations in a Chinese Patient with Long-Term Severe Hypertriglyceridemia and Recurrent Acute Pancreatitis.

Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis

Identification and Functional Characterization of a Novel Heterozygous Missense Variant in the LPL Associated with Recurrent Hypertriglyceridemia‐induced Acute Pancreatitis in Pregnancy

Identification and functional characterization of mutations in LPL gene causing severe hypertriglyceridaemia and acute pancreatitis.

Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass

Chaiqin chengqi decoction treatment mitigates hypertriglyceridemia-associated acute pancreatitis by modulating liver-mediated glycerophospholipid metabolism

Association of admission serum triglyceride levels with intensive care unit hospitalization rates in acute pancreatitis patients: A retrospective study

A Novel Lipoprotein Lipase Gene Missense Mutation in Chinese Patients with Severe Hypertriglyceridemia and Pancreatitis

Hereditary Extremely Hypertriglyceridemic Mice Are More Susceptible to Acute Pancreatitis

Fatty Liver, Statin Therapy, and the Risk of Hypertriglyceridemic Acute Pancreatitis

Significant but partial lipoprotein lipase functional loss caused by a novel occurrence of rare LPL biallelic variants

Alcohol predisposes obese mice to acute pancreatitis via adipose triglyceride lipase-dependent visceral adipocyte lipolysis

Liver Enzymes Mediate the Association Between Aldehydes Co-Exposure and Hypertriglyceridemia

A Heterozygous LMF1 Gene Mutation (c.1523C>T), Combined With an LPL Gene Mutation (c.590G>A), Aggravates the Clinical Symptoms in Hypertriglyceridemia

A genome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population.

Characterizing genetic profiles for high triglyceride levels in U.S. patients of African ancestry

Lipid levels and risk of acute pancreatitis using bidirectional Mendelian randomization